Why do patients with McArdle's disease have decreased exercise capacity?

Neurology

Volumn 50, Issue 1, 1998, Pages 6-7

  Ruff, Robert L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXERCISE; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; MUSCLE FATIGUE; NOTE; PATHOPHYSIOLOGY;

EXERTION; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MUSCLE FATIGUE;

EID: 0031614593     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.50.1.6     Document Type: Editorial

References (19)

1. DiMauro S, Tsujino S. Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1554-1576.
2. Rowland LP. Cramps, spasms and muscle stiffness. Rev Neurol (Paris) 1985;141:261-273.
3. Lewis SF, Haller RG. Fatigue in skeletal muscle disorders. In: Atlan G, Belivau L, Bouissou P, eds. Muscle fatigue: biochemical chemical and physiological aspects. Paris: Masson, 1991:119-134.
4. Kaminski HJ, Ruff RL. Endocrine myopathies (hyper- and hypofunction of adrenal, thyroid, pituitary glands and iatrogenic glucocorticoid myopathy). In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. New York: McGraw-Hill, 1994:1726-1753.
5. + ATPase in McArdle disease. Neurology 1998;50:37-40.
6. Rowland LP, Araki S, Carmel P. Contracture in McArdle's disease: stability of adenosine triphosphate during contracture in phosphorylase-deficient muscle. Arch Neurol 1965;13:541-544.
7. Argov Z, Bank WJ, Maris J, Chance B. Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy. Neurology 1987;37:1720-1724.
8. 31 P nuclear magnetic resonance. N Engl J Med 1981;304:1338-1342.
9. 31 P NMR studies of control of mitochondrial function in phosphofructokinase-deficient human skeletal muscle. Proc Natl Acad Sci USA 1982;79:7714-7718.
10. Bertocci LA, Haller RG, Lewis SF, Fleckenstein JL, Nunnally RL. Abnormal high-energy phosphate metabolism in human muscle phosphofructokinase deficiency. J Appl Physiol 1991;70:1201-1207.
11. 31 P nuclear magnetic resonance spectroscopy. Ann Neurol 1987;22:46-51.
12. Argov Z, Bank WJ, Boden B, Young R, Chance B. Phosphorus magnetic resonance spectroscopy of partially blocked muscle glycolysis: an in vivo study of phosphoglycerate mutase deficiency. Arch Neurol 1987;44:614-617.
13. Duboc D, Jehenson P, Tran Dinh S, Marsac C, Syrota A, Fardeau M. Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis. Neurology 1987;37:663-671.
14. Brumback RA. Iodoacetate inhibition of glyceraldehyde 3-phosphate dehydrogenase as a model of human myophosphorylase deficiency(McArdle's disease) and phosphofructokinase deficiency (Tarui's disease). J Neurol Sci 1980;8:383-398.
15. Ruff RL, Weissman J. Iodoacetate-induced contracture in rat skeletal muscle: possible role of ADP. Am J Physiol 1991;261(Cell Physiol 30):C828-C836.
16. Ruff RL, Weissman J. Iodoacetate-induced skeletal muscle contracture: changes in ADP, calcium, phosphate and pH. Am J Physiol 1995;268(Cell Physiol 37):C317-C322.
17. 2+ sensitivity cause iodoacetate-induced muscle contractures. J Appl Physiol 1996;81:1230-1239.
18. + transport in skeletal muscle. Physiol Rev 1986;66:542-580.
19. Ruff RL. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fibre types. Acta Physiol Scand 1996;156:159-168.